Results 211 to 220 of about 77,670 (298)

ACE2 and Ang-(1-7) Confer Protection Against Development of Diabetic Retinopathy [PDF]

, 2011
Amrisha Verma, Zhiying Shan, Bo Lei, Lihui Yuan, Xuan Liu, Takahiko Nakagawa, Maria B. Grant, Alfred S. Lewin, William W. Hauswirth, Mohan K. Raizada, Qiuhong Li   +10 more
openalex   +1 more source

ACE2 Elevation in Severe COVID-19

American Journal of Respiratory and Critical Care Medicine, 2021
Roman Reindl-Schwaighofer, Sebastian Hödlmoser, Farsad Eskandary, Marko Poglitsch, Diana Bonderman, Robert Strassl, Judith H. Aberle, Rainer Oberbauer, Alexander Zoufaly, Manfred Hecking   +9 more
openaire   +3 more sources

Biomimetic Recognition of SARS‐CoV‐2 Receptor‐Binding Domain N‐Glycans by an Antiviral Synthetic Receptor

ChemBioChem, Volume 26, Issue 7, April 1, 2025.
Glycan‐binding agents may be a key asset in the development of new antivirals against enveloped viruses. Using a combination of glycoengineering and mass spectrometry techniques, we present here direct evidence of biomimetic recognition of the N‐glycans exposed on the receptor‐binding domain (RBD) of the wild‐type spike protein of SARS‐CoV‐2 by a ...
Carlo Santambrogio, Mirco Toccafondi, Lorena Donnici, Elisa Pesce, Raffaele De Francesco, Renata Grifantini, Erika Ponzini, Francesco Milanesi, Marco Fragai, Cristina Nativi, Stefano Roelens, Rita Grandori, Oscar Francesconi   +12 more
wiley   +1 more source

Fullerenol C60(OH)40 Nanoparticles and Ectoine Protect Human Nasal Epithelial Cells Against the Cytokine Storm After Addition of the Full-Length Spike Protein from SARS-CoV-2

International Journal of Nanomedicine
Malwina Sosnowska,1 Mateusz Wierzbicki,1 Barbara Nasiłowska,2 Totka Nikolaeva Bakalova,3 Klara Piotrowska,4 Barbara Strojny-Cieślak,1 Ewa Sawosz,1 Marta Kutwin1 1Department of Nanobiotechnology, Institute of Biology, Warsaw University of ...
Sosnowska M, Wierzbicki M, Nasiłowska B, Bakalova TN, Piotrowska K, Strojny-Cieślak B, Sawosz E, Kutwin M   +7 more
doaj  

CRISPR-Cas9 genetic screens reveal regulation of TMPRSS2 by the Elongin BC-VHL complex. [PDF]

Sci Rep
Gabaev I, Rowland A, Jovanovic E, Gawden-Bone CM, Crozier TWM, Teixeira-Silva A, Greenwood EJD, Gerber PP, Wit N, Nathan JA, Matheson NJ, Lehner PJ.   +11 more
europepmc   +1 more source

Loss of ACE2 augments angiotensin II-induced myocardial hypertrophy and remodeling with increased Profilin-1 expression [PDF]

, 2011
Z. Jiuchang, Haiyan Jin, O. Gavín, Yongzhi Xi, Gao Pingjin, Zhu Dingliang, K. Zamaneh   +6 more
openalex   +1 more source

Peptides Corresponding to the Receptor‐Binding Domain (RBD) of Several SARS‐CoV‐2 Variants Of Concern Prevent Recognition of the Human ACE2 Receptor and Consecutive Cell Infections

ChemMedChem, Volume 20, Issue 7, April 1, 2025.
Despite the end of the COVID‐19 pandemic, SARS‐CoV‐2 will remain a constant factor in our lives. For this reason, the development of new preventive therapeutics is necessary. Here, the first steps were taken by testing peptides for their inhibitory activity on the binding between the human ACE‐2 receptor and the RBD of the virus.
Mandy Schwarze, Alexandra Brakel, Ralf Hoffmann, Andor Krizsan   +3 more
wiley   +1 more source

The influence of SARS-CoV-2 spike protein exposure on retinal development in the human retinal organoids. [PDF]

Cell Biosci
Gong J, Ge L, Zeng Y, Yang C, Luo Y, Kang J, Zou T, Xu H.   +7 more
europepmc   +1 more source

Angiotensin converting enzyme 2 (ACE2) activity in fetal calf serum: implications for cell culture research

, 2008
John Lubel, Chandana B. Herath, Elena Velkoska, David Casley, Louise M. Burrell, Peter Angus   +5 more
openalex   +2 more sources

mRNA-encoded ACE2 decoy lipid nanoparticles for neutralizing SARS-CoV-2 variants. [PDF]

Mol Ther Nucleic Acids
Guimarães LC, Seabra Ferreira HA, Goulart Guimarães PP.   +2 more
europepmc   +1 more source